Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients

被引:141
作者
Kimerling, ME
Phillips, P
Patterson, P
Hall, M
Robinson, CA
Dunlap, NE
机构
[1] Univ Alabama, Sch Publ Hlth, Dept Int Hlth, Div Int Hlth, Birmingham, AL 35294 USA
[2] Univ Alabama, Sch Med, Div Pulm & Crit Care Med, Birmingham, AL USA
[3] Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL USA
关键词
drug monitoring; intestinal absorption; tuberculosis;
D O I
10.1378/chest.113.5.1178
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Despite the use of directly observed therapy (DOT) by tuberculosis control programs, patient treatment failure, relapse, and acquired drug resistance remain problematic in a small number. We investigated serum drug levels in non-HIV-infected tuberculosis patients who were receiving DOT by the health department and did not respond to treatment as expected. Methods: The indications for checking levels were as follows: (1) slow clinical response or failure to convert the sputum culture within 12 weeks; (2) treatment failure, early disease relapse <13 1 months since being declared cured; (3) relapse, late disease reactivation greater than or equal to 13 months since being declared cured; and (4) acquired drug resistance while receiving DOT. Baseline characteristics of control subjects who responded to therapy as expected were compared. Venous blood for analysis was obtained at 2 h after directly observed ingestion and measured by high-performance liquid chromatography. Results: Twenty-four patients receiving daily or twice-weekly standard therapy with isoniazid (INH, 300 or 900 mg) and rifampin (RMP, 600 mg) were identified; 22 had drug levels evaluated at 2 h, For INH, 15 of 22 patients (68%) had levels less than the reported target range. For RMP, 14 of 22 patients (64%) had low levels. Among the 14 patients receiving INH, 900 mg, and RMP, 600 mg, 4 (29%) had very low levels of both. Use of a combination INH/RMP tablet was associated with lower INH levels (p=0.04); however, RMP levels were higher (p<0.02). Alcohol use was associated with significantly higher RMP (p<0.01) serum concentrations. Conclusions: Important questions remain concerning the utility and timing of serum drug measurements. However, if a patient is not responding to therapy as expected and one is assured that the Mycobacterium tuberculosis organism is susceptible to the drugs given and that the patient is taking the medication as prescribed, drug level monitoring should be considered.
引用
收藏
页码:1178 / 1183
页数:6
相关论文
共 17 条
[1]  
Acocella G, 1989, Bull Int Union Tuberc Lung Dis, V64, P38
[2]  
[Anonymous], 1992, DRUG THER
[3]  
BERNING SE, 1992, NEW ENGL J MED, V327, P1817, DOI 10.1056/NEJM199212173272514
[4]   UPDATE ON RIFAMPIN DRUG-INTERACTIONS .2. [J].
BORCHERDING, SM ;
BACIEWICZ, AM ;
SELF, TH .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (04) :711-716
[5]  
BUNIVA G, 1983, INT J CLIN PHARM TH, V21, P404
[6]  
Cavenaghi R, 1989, Bull Int Union Tuberc Lung Dis, V64, P36
[7]  
Conover W. J., 1980, PRACTICAL NONPARAMET
[8]   SIMULTANEOUS MICRODETERMINATION OF RIFAMPIN, DEACETYLRIFAMPIN, ISONIAZID, AND ACETYLISONIAZID IN PLASMA BY LIQUID-CHROMATOGRAPHY WITH DUAL ELECTROCHEMICAL AND SPECTROPHOTOMETRIC DETECTION [J].
ELYAZIGI, A ;
RAINES, DA .
PHARMACEUTICAL RESEARCH, 1992, 9 (06) :812-816
[9]   RAPID LIQUID-CHROMATOGRAPHIC METHOD FOR THE ESTIMATION OF ISONIAZID AND PYRAZINAMIDE IN PLASMA AND URINE [J].
GAITONDE, CD ;
PATHAK, PV .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 532 (02) :418-423
[10]   LOW SERUM LEVELS OF ORAL ANTIMYCOBACTERIAL AGENTS IN PATIENTS WITH DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE [J].
GORDON, SM ;
HORSBURGH, CR ;
PELOQUIN, CA ;
HAVLIK, JA ;
METCHOCK, B ;
HEIFETS, L ;
MCGOWAN, JE ;
THOMPSON, SE .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1559-1562